- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 31, 2026 | 678.5M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 662.5M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 625.28M sh |
| Capex | FY 2025 · Dec 31, 2025 | $5.52K |
| Capex | FY 2025 · Dec 31, 2024 | $0 |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$789.1K |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$1.7M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $1.8K |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $2.16K |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$30.15M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$19.81M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | −$12.15M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $31.59M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $25.75M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $37.17M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $30.65M |
| Current Assets | FY 2025 · Dec 31, 2025 | $1.31M |
| Current Assets | FY 2025 · Dec 31, 2024 | $1.02M |
| Total Assets | FY 2025 · Dec 31, 2025 | $7.02M |
| Total Assets | FY 2025 · Dec 31, 2024 | $10.84M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.02 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.02 |
| Net Income | FY 2025 · Dec 31, 2025 | −$11.13M |
| Net Income | FY 2025 · Dec 31, 2024 | −$9.91M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$3.35M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | −$3.63M |
| Gross Profit | FY 2025 · Dec 31, 2025 | −$2.08M |
| Gross Profit | FY 2025 · Dec 31, 2024 | −$2.93M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $3.45M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $3.76M |
| Revenue | FY 2025 · Dec 31, 2025 | $1.36M |
| Revenue | FY 2025 · Dec 31, 2024 | $820.14K |
| Stock Repurchased | FY 2025 · Mar 30, 2015 | $350K |